45. Dreon DM, Fernstrom HA, Williams PT, et al. A very low-fat diet is not associated with improved lipoprotein profiles in men with a predominance of large, low-density lipoproteins. Am J Clin Nutr. 1999 Mar; 69 (3): 411–418.

46. Turpeinen O, Karvonen MJ, Pekkarinen M, et al. Dietary prevention of coronary heart disease: the Finnish Mental Hospital Study. Int J Epidemiol. 1979 Jun; 8 (2): 99–118.

47. Parodi PW. Has the association between saturated fatty acids, serum cholesterol and coronary heart disease been over emphasized? Int Dairy J. 2009 Jun-Jul; 19 (6–7): 345–361.

48. Dayton S, Pearce ML. Diet high in unsaturated fat. A controlled clinical trial. Minn Med. 1969 Aug; 52 (8): 1237–1242.

49. Loffredo L, Perri L, Di Castelnuovo A, et al. Supplementation with vitamin E alone is associated with reduced myocardial infarction: a meta-analysis. Nutr Metab Cardiovasc Dis. 2015 Apr; 25 (4): 354–363.

50. Ramsden CE, Hibbeln JR, Majchrzak SF, et al. n-6 fatty acid-specific and mixed polyunsaturate dietary interventions have different effects on CHD risk: a meta-analysis of randomised controlled trials. Br J Nutr. 2010 Dec; 104 (11): 1586–1600.

51. Там же.

52. Frantz ID Jr., Dawson EA, Ashman PL, et al. Test of effect of lipid lowering by diet on cardiovascular risk. The Minnesota Coronary Survey. Arteriosclerosis. 1989 Jan-Feb; 9 (1): 129–135.

53. Baum SJ, Kris-Etherton PM, Willett WC, et al. Fatty acids in cardiovascular health and disease: a comprehensive update. J Clin Lipidol. 2012 May-Jun; 6 (3): 216–234.

54. Christakis G, Rinzler SH, Archer M, et al. Effect of the Anti-Coronary Club program on coronary heart disease. Risk-factor status. JAMA. 1966 Nov 7; 198 (6): 597–604.

55. DiNicolantonio JJ. The cardiometabolic consequences of replacing saturated fats with carbohydrates or Ω-6 polyunsaturated fats: Do the dietary guidelines have it wrong? Open Heart, 2014 Feb 8;1(1):e000032. doi:10.1136/openhrt-2013-000032.

56. Christakis G, Rinzler SH, Archer M, et al. The anti-coronary club. A dietary approach to the prevention of coronary heart disease – a seven-year report. Am J Public Health Nations Health. 1966 Feb; 56 (2): 299–314.

57. Rose GA, Thomson WB, Williams RT. Corn oil in treatment of ischaemic heart disease. Br Med J. 1965 Jun 12; 1 (5449): 1531–1533.

58. Там же.

59. de Lorgeril M, Salen P, Martin JL, et al. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation. 1999 Feb 16; 99 (6): 779–785.

60. de Lorgeril M, Renaud S, Mamelle N, et al. Mediterranean alpha-linolenic acidrich diet in secondary prevention of coronary heart disease. Lancet. 1994 Jun 11; 343 (8911): 1454–1459.

61. Estruch R, Ros E, Salas-Salvado J, et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med. 2013 Apr 4; 368 (14): 1279–1290.

62. de Lorgeril M, Salen P, Defaye P, et al. Recent findings on the health effects of omega-3 fatty acids and statins, and their interactions: do statins inhibit omega-3? BMC Med. 2013; 11: 5.

63. DiNicolantonio JJ, Niazi AK, McCarty MF, et al. Omega-3s and cardiovascular health. Ochsner J. 2014 Fal l; 14 (3): 399–412.

64. DiNicolantonio JJ, Niazi AK, O’Keefe JH, Lavie CJ. Explaining the recent fish oil trial “failures”. J Glycomics Lipidomics. 2013; 3 (1): e112. doi:10.4172/2153-0637.1000e112.

65. Burr ML, Fehily AM, Gilbert JF, et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet. 1989 Sep 30; 2 (8666): 757–761.

66. Burr ML, Sweetham PM, Fehily AM. Diet and reinfarction. Eur Heart J. 1994 Aug; 15 (8): 1152–1153.

67. Marchioli R, Barzi F, Bomba E, et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione. Circulation. 2002 Apr 23; 105 (16): 1897–1903.

68. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico. Lancet. 1999 Aug 7; 354 (9177): 447–455.

69. Tavazzi L, Maggioni AP, Marchioli R, et al. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet. 2008 Oct 4; 372 (9645): 1223–1230.

70. Yokoyama M, Origasa H, Matsuzaki M, et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet. 2007 Mar 31; 369 (9567): 1090–1098.

71. Там же.

72. Tanaka K, Ishikawa Y, Yokoyama M, et al. Reduction in the recurrence of stroke by eicosapentaenoic acid for hypercholesterolemic patients: subanalysis of the JELIS trial. Stroke. 2008 Jul; 39 (7): 2052–2058.

73. Einvik G, Klemsdal TO, Sandvik L, et al. A randomized clinical trial on n-3 polyunsaturated fatty acids supplementation and all-cause mortality in elderly men at high cardiovascular risk. Eur J Cardiovasc Prev Rehabil. 2010 Oct; 17 (5): 588–592.

74. Simopoulos AP. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother. 2002 Oct; 56 (8): 365–379.

75. DiNicolantonio JJ, Meier P, O’Keefe JH. Omega-3 polyunsaturated fatty acids for the prevention of cardiovascular disease: do formulation, dosage & comparator matter? Mo Med. 2013 Nov-Dec; 110 (6): 495–498.

76. Simopoulos AP, Leaf A, Salem N Jr. Essentiality of and recommended dietary intakes for omega-6 and omega-3 fatty acids. Ann Nutr Metab. 1999; 43 (2): 127–130.

77. Harris WS, Von Schacky C. The omega-3 index: a new risk factor for death from coronary heart disease? Prev Med. 2004 Jul; 39 (1): 212–220.

Глава вторая

1. Lee KW, Lee HJ, Cho HY, et al. Role of the conjugated linoleic acid in the prevention of cancer. Crit Rev Food Sci Nutr. 2005; 45 (2): 135–144.

2. Wang Y, Lu J, Ruth MR, et al. Trans-11 vaccenic acid dietary supplementation induces hypolipidemic effects in JCR: LA-cp rats. J Nutr. 2008 Nov; 138 (1): 2117–2122.

3. Micha R, Mozaffarian D. Trans fatty acids: effects on cardiometabolic health and implications for policy. Prostaglandins Leukot Essent Fatty Acids. 2008; 79 (3–5): 147–152.